About this trial
This study aims to study the relationships between obesity, circadian rhythm, and aging. The investigators set up a prospective cohort registry for morbid obesity, obesity, and normal subjects with annual follow-up. The cohort aims to investigate the pathophysiological, molecular, genetic, and cellular aspects of the relationships between obesity, circadian deregulation, and impacts on aging. Clinical data, questionnaires, biological material, and molecular signatures will be collected and investigated.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 20 years old
Body mass index ≥ 24 kg/m2
For normal subjects, Body mass index < 24 kg/m2
Disqualifiers
No inform consent
Use of steroid medications
Severe systemic diseases or organ failure with estimated life expectancy of 6 months or less
Trial population
Subjects will be recruited from the general population including healthcare facility and non-health care settings. Healthcare facility includes university based hospital and primary care clinics. Non-health care settings include schools, subjects families, and employment agencies.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Body weight
Secondary outcomes
Major Cardiovascular Adverse Events
Sleep quality as assessed by Pittsburgh Sleep Quality Index (PSQI) questionnaire
Personal chronotype (biological clock) as assessed by Munich Chronotype Questionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.